Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases (2020)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.bbmt.2020.07.003
- Subjects: CÉLULAS-TRONCO; DOENÇA ENXERTO-HOSPEDEIRO; INFÂNCIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Biology of blood and marrow transplantation
- ISSN: 1083-8791
- Volume/Número/Paginação/Ano: v. 26, n. 10, p. 1923-1929, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
FERNANDES, Juliana Folloni et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biology of blood and marrow transplantation, v. 26, n. 10, p. 1923-1929, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.07.003. Acesso em: 20 maio 2024. -
APA
Fernandes, J. F., Nichele, S., Arcuri, L. J., Ribeiro, L., Zamperlini-Netto, G., Loth, G., et al. (2020). Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biology of blood and marrow transplantation, 26( 10), 1923-1929. doi:10.1016/j.bbmt.2020.07.003 -
NLM
Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, Rodrigues ALM, Kuwahara C, Koliski A, Rocha VG. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases [Internet]. Biology of blood and marrow transplantation. 2020 ; 26( 10): 1923-1929.[citado 2024 maio 20 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.003 -
Vancouver
Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, Rodrigues ALM, Kuwahara C, Koliski A, Rocha VG. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases [Internet]. Biology of blood and marrow transplantation. 2020 ; 26( 10): 1923-1929.[citado 2024 maio 20 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.003 - Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis
- Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
- Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
- Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population
- Prevalence of SMIM1 c.64_80del17 homozygotes in southeastern Brazil [Carta]: the Vel-negative phenotype
- Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
- Current role of interferon in hairy cell leukemia therapy: a timely decision
- Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.[Carta]
- Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis
- Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay
Informações sobre o DOI: 10.1016/j.bbmt.2020.07.003 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
